Free Trial
OTCMKTS:RHHBY

Roche (RHHBY) Stock Price, News & Analysis

Roche logo
$40.55 -0.36 (-0.88%)
As of 10:02 AM Eastern

About Roche Stock (OTCMKTS:RHHBY)

Key Stats

Today's Range
$40.54
$40.87
50-Day Range
$37.34
$41.95
52-Week Range
$33.76
$44.31
Volume
27,202 shs
Average Volume
2.58 million shs
Market Capitalization
$258.63 billion
P/E Ratio
N/A
Dividend Yield
2.15%
Price Target
N/A
Consensus Rating
Moderate Buy

Company Overview

Roche Holding AG (OTCMKTS:RHHBY) is a Swiss multinational healthcare company headquartered in Basel, Switzerland. Founded in 1896 by Fritz Hoffmann-La Roche, the firm has grown into a global leader in pharmaceuticals and diagnostics. With operations spanning more than 150 countries, Roche is known for its integrated approach, combining innovative drug development with state-of-the-art diagnostic solutions to drive personalized healthcare.

In its Pharmaceuticals Division, Roche concentrates on targeted therapies for serious diseases across oncology, immunology, neuroscience and ophthalmology. The company has pioneered several breakthrough treatments, including monoclonal antibodies and small-molecule inhibitors designed to address unmet medical needs. Through sustained investment in research and development, Roche advances projects from early discovery through clinical trials, often collaborating with academic institutions and biotechnology partners to accelerate the progress of novel medicines.

Roche’s Diagnostics Division provides a broad portfolio of systems and tests that support laboratory-based, molecular and point-of-care diagnostics. Its platforms facilitate early disease detection, patient monitoring and treatment management across a range of conditions, from infectious diseases to genetic testing. By integrating data analytics and digital tools, the division aims to enhance laboratory efficiency and deliver actionable insights for healthcare providers and patients alike.

Governed by a board chaired by Christoph Franz and led operationally by Chief Executive Officer Severin Schwan, Roche emphasizes a patient-centric vision and a long-term commitment to innovation. The company holds a majority stake in Genentech, its U.S. biotechnology affiliate, and maintains strategic collaborations worldwide. As it continues to expand its pipeline and diagnostic capabilities, Roche seeks to leverage precision medicine and digital health solutions to address evolving global healthcare challenges.

AI Generated. May Contain Errors.

Receive RHHBY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Roche and its competitors with MarketBeat's FREE daily newsletter.

RHHBY Stock News Headlines

Changes to the Roche Enlarged Corporate Executive Committee
RHHBY - Roche Holding AG ADR Trailing Returns - Morningstar
Israel-Iran WAR Could Destroy Trump's Presidency
The missiles are already flying. Israel and Iran are now in direct military conflict — and this couldn't have happened at a worse time. Trump is already dealing with Biden's $34 trillion debt bomb AND now a Middle East war. This is exactly what the "resistance" has been waiting for.
RHHBY Roche Holding AG - Seeking Alpha
RHHBY - Roche Holding AG ADR Key Metrics - Morningstar
RHHBY - Roche Holding AG ADR Dividends - Morningstar
See More Headlines

RHHBY Stock Analysis - Frequently Asked Questions

Roche's stock was trading at $34.88 at the beginning of the year. Since then, RHHBY stock has increased by 17.3% and is now trading at $40.91.
View the best growth stocks for 2025 here
.

Roche subsidiaries include these companies: Inflazome, Stratos Genomics, Promedior, Spark Therapeutics, Tusk Therapeutics, Flatiron Health, Ignyta, and more.

Shares of RHHBY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Today
6/30/2025
Next Earnings (Estimated)
7/24/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Large Cap Pharma
Sub-Industry
Personal Services
Current Symbol
OTCMKTS:RHHBY
CIK
N/A
Employees
103,249
Year Founded
1896

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
14.56
P/E Growth
2.61
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$68.73 billion
Cash Flow
$3.30 per share
Price / Cash Flow
12.41
Book Value
$6.44 per share
Price / Book
6.35

Miscellaneous

Outstanding Shares
6,377,940,000
Free Float
N/A
Market Cap
$260.92 billion
Optionable
Not Optionable
Beta
0.46

Social Links

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report

This page (OTCMKTS:RHHBY) was last updated on 6/30/2025 by MarketBeat.com Staff
From Our Partners